Abstract
Purpose
The aim of this prospective study was to evaluate the feasibility, safety, and efficacy of sequential transarterial chemoembolization (TACE) for patients with unresectable advanced hepatocellular carcinoma (HCC).
Methods
Twenty-one consecutive patients with unresectable T3 and T4 HCC were treated by sequential TACE (median time interval between treatments 7 weeks) up to six times with an emulsion of lipiodol, epirubicin, and cisplatin. All TACE procedures were performed as unilobar or whole-liver chemoembolization.
Results
An average of 3.9 TACE procedures were performed per patient. One primary and two secondary technical failures occurred. No procedural death was observed. After exclusion of the patient with the primary technical failure and 3 patients with extrahepatic disease, the survival rates for the remaining 17 patients at 6, 12, 18, and 24 months were 70.6%, 52.9%, 44.1%, and 33.1%, respectively.
Conclusion
Sequential TACE is a safe procedure in patients with unresectable advanced HCC and feasible in most cases. It seems to prolong the survival time compared with historical series of untreated patients.
Similar content being viewed by others
References
Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L (1991) Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 36:962–972
Peters RL (1976) Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York, pp 107–169
Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K (1984) Prognosis of primary hepatocellular carcinoma. Hepatology 4:3S-6S
Ringe B, Pichlmayr R, Wittekind C, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients. World J Surg 15: 270–285
Pichlmayr R, Weimann A, Steinhoff G, Ringe B (1992) Liver transplantation for hepatocellular carcinoma: Clinical results and future aspects. Cancer Chemother Pharmacol 31 [Suppl 1]: S157-S161
Falkson G, Moertel CG, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. Cancer 42:2149–2156
Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T (1983) Work in progress: Transcatheter management of primary carcinoma of the liver. Radiology 147:51–55
Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G (1992) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: A study of 207 patients. Cancer 69:925–929
Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C (1976) Transcatheter occlusion of abdominal tumors. Radiology 120:539–545
Novell JR, Markham NI, Hobbs KEF (1989) New hope in irresectable hepatoma? Hepatogastroenterology 36:258–261
Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M (1989) Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64:1586–1594
Monden M, Okamura J, Sakon M, Gotoh M, Kobayashi K, Umeshita K, Yamada T, Kuroda C, Sakurai M, Mori T (1989) Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinoma. Cancer Chemother Pharmacol 23 [Suppl]: S90-S95
Hashimoto T, Nakamura H, Hori S, Tomoda K, Nakanishi K, Murakami T, Kozuka T, Monden M, Gotoh M, Kuroda C, Wakasa K, Sakurai M (1995) Hepatocellular carcinoma: Efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol 18:82–86
Monna T, Kanno T, Marumo T, Harihara S, Kuroki T, Yamamoto S, Kobayashi N, Sato M, Nakamura K, Nakatsuka H, Onoyama Y, Yamada R (1982) A comparison of transcatheter arterial embolization with one shot therapy for the patients with hepatic cell carcinoma. Gastroenterol Jpn 17:542–548
Lin D, Liaw Y, Lee T, Lai C (1988) Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Gastroenterology 94:453–456
Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K (1991) Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: An analysis by the Cox proportional hazard model. Cancer 68:2150–2154
Pirschel J, Lanchart W (1991) Chemoembolization primärer Leberkarzinome mit Epirubicin-Lipiodol. Fortschr Geb Rontgenstr Nuklearmed 155:409–415
Vetter D, Wenger J, Bergier J, Doffoel M, Bockel R (1991) Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of aWestern comparative study in 60 patients. Hepatology 13:427–433
Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A (1992) Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 163:387–394
Hsieh M, Chang W, Wang L, Chen S, Chuang W, Lu S, Wu D (1992) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 31 [Suppl I]: S82-S85
Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang K, Sakurai M, Kuroda C, Okamura J, Mori T (1992) Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol 31 [Suppl I]:S38-S44
Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261
International Union Against Cancer (1993). TNM-Atlas Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 3rd edn. Springer, Berlin Heidelberg New York, pp 104–111
Maki S, Komo T, Maeda H (1985) Image enhancement in computed tomography for sensitive diagnosis of liver cancer and semiquantitation of tumour selective drug targeting with oily contrast. Cancer 56:751–757
Häussler MD, Pfeifer T, Safi F, Friedrich JM, Bargon G (1993) CT-Monitoring bei regionaler Chemotherapie von Lebermetastasen. In: Reiser M, Steudel A, Hirner A, Kania U (eds) Lebertumoren und portale Hypertension: Radiologische und chirurgische Aspekte. Springer, Berlin Heidelberg New York, pp 241–247
Lautt WW, Greenway CV (1987) Conceptual review of the hepatic vascular bed. Hepatology 7:952–963
Kan Z, Wallace S (1994) Sinusoidal embolization: Impact of iodized oil on hepatic microcirculation. J Vasc Intervent Radiol 5:881–886
Yumoto Y, Jinno K, Tokuyama K, Araki Y, Ishimitsu T, Maeda H, Konno T, Iwamoto S, Ohnishi K, Okuda K (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154:19–24
Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J (1993) Effects of hepatic artery embolization with Lipiodol and Gelatin sponge particles on normal swine liver. Cardiovasc Intervent Radiol 16:348–354
Pentecost MJ, Daniels JR, Teitelbaum GP, Stanley P (1993) Hepatic chemoembolization safety with portal vein thrombosis. J Vasc Intervent Radiol 4:347–351
Toia D, Becker C, Baer HU (1995) Patterns of recurrence of hepatocellular carcinoma after surgery: A radiologic follow-up study. Eur Radiol 5 [Suppl]:S54
Masutani S, Sasaki Y, Imaoka S, Iwamoto S, Ohashi I, Kameyama M, Kabuto T, Ishikawa O, Furukawa H, Koyama H, Iwanaga T (1994) The prognostic significance of surgical margin in liver resection of patients with hepatocellular carcinoma. Arch Surg 129:1025–1030
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaeger, H.J., Mehring, UM., Castañeda, F. et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 19, 388–396 (1996). https://doi.org/10.1007/BF02577625
Issue Date:
DOI: https://doi.org/10.1007/BF02577625